Project 5 - Several studies have demonstrated an association between low cholesterol and both violent death (including suicide) and psychiatric disorders such as antisocial disorder, affective disorders, personality disorders and conduct disorder. Based on this observation, we hypothesized that carriers of mutations associated with cholesterol synthesis might also have a higher risk for behavioral problems.
The aim of this study is to characterize the behavioral phenotype in carriers of disorders of sterol metabolism associated with low cholesterol, including Smith-Lemli Opitz syndrome, CK syndrome, SC4MOL deficiency, CHILD syndrome and chondrodysplasia punctata 2. A total of 144 individuals (75 subjects and 69 controls) will be recruited from the 5 sites (UBC, OHSU, UNMC, CCHMC, and UPMC) as part of the STAIR consortium. Our study will be done in 2 parts. Firstly, well validated personality disorder questionnaires (Dimensional Assessment of Personality Pathology-Basic Questionnaire [DAPP-BQ], the Schedule for Nonadaptive and Adaptive Personality-2 [SNAP-2]) will be administered to all subjects and 30 controls to identify aberrant behavioral traits. Secondly, to clarify the functional brain changes associated with these behaviors, the hemodynamic responses to working memory tasks will be examined using fMRI. Fifty one subjects (chosen randomly from the above stated 75 subjects) and 39 controls will undergo this part of the study. Behavioral and fMRI Data will be analyzed at UBC with the help of the the STAIR statistical core. Based on our preliminary data, we anticipate finding significant changes in behavior amonst carriers of sterol biosynthesis disorders compared to controls. In addition, we predict that the neuron activation seen in carriers of sterol metabolism disorders will be significantly lower then controls. The long term goal of this study is through the use of the proposed tools, find new markers that could potentially lead to improved behavioral therapies not only for disorders of cholesterol synthesis but also for individuals in the general population that suffer from similar behaviors.
This study will provide further insight into the association between low cholesterol and abnormal behaviors. Our increased understanding of these behaviors will help in the development of new and improved therapeutic interventions for these individuals as well as the broader general population.
|Merkens, Mark J; Sinden, Nancy L; Brown, Christine D et al. (2014) Feeding impairments associated with plasma sterols in Smith-Lemli-Opitz syndrome. J Pediatr 165:836-41.e1|
|DeBarber, Andrea E; Luo, Jenny; Star-Weinstock, Michal et al. (2014) A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newborns. J Lipid Res 55:146-54|
|DeBarber, Andrea E; Luo, Jenny; Giugliani, Roberto et al. (2014) A useful multi-analyte blood test for cerebrotendinous xanthomatosis. Clin Biochem 47:860-3|
|He, Miao; Smith, Laurie D; Chang, Richard et al. (2014) The role of sterol-C4-methyl oxidase in epidermal biology. Biochim Biophys Acta 1841:331-5|
|Liu, Wei; Xu, Libin; Lamberson, Connor R et al. (2013) Assays of plasma dehydrocholesteryl esters and oxysterols from Smith-Lemli-Opitz syndrome patients. J Lipid Res 54:244-53|
|Kanungo, Shibani; Soares, Neelkamal; He, Miao et al. (2013) Sterol metabolism disorders and neurodevelopment-an update. Dev Disabil Res Rev 17:197-210|
|Simon, Anna; Drenth, Joost P H; Matern, Dietrich et al. (2013) Long chain fatty acid (Lcfa) abnormalities in hyper Igd syndrome (Hids) and Familial Mediterranean Fever (Fmf): new insight into heritable periodic fevers. Mol Genet Metab 108:166-71|
|Hager, Elizabeth J; Piganelli, Jon D; Tse, Hubert M et al. (2012) Aberrant expression of costimulatory molecules in splenocytes of the mevalonate kinase-deficient mouse model of human hyper-IgD syndrome (HIDS). J Inherit Metab Dis 35:159-68|
|DeBarber, Andrea E; Eroglu, Yasemen; Merkens, Louise S et al. (2011) Smith-Lemli-Opitz syndrome. Expert Rev Mol Med 13:e24|
|Monson, Dinelli M; DeBarber, Andrea E; Bock, Charles J et al. (2011) Cerebrotendinous xanthomatosis: a treatable disease with juvenile cataracts as a presenting sign. Arch Ophthalmol 129:1087-8|
Showing the most recent 10 out of 13 publications